Quality of life in a randomized trial of early closure of temporary ileostomy after rectal resection for cancer (EASY trial).
Published: 23rd November 2017
Authors: J. Park, A. K. Danielsen, E. Angenete, D. Bock, A. C. Marinez, E. Haglind et al.
A temporary ileostomy may reduce symptoms from anastomotic leakage after rectal cancer resection. Earlier results of the EASY trial showed that early closure of the temporary ileostomy was associated with significantly fewer postoperative complications. The aim of the present study was to compare health‐related quality of life (HRQOL) following early
Early closure of a temporary ileostomy (at 8–13 days) was compared with late closure (at more than 12 weeks) in a multicentre RCT (EASY) that included patients who underwent rectal resection for cancer. Inclusion of participants was made after index surgery. Exclusion criteria were signs of anastomotic leakage, diabetes mellitus, steroid treatment, and signs of postoperative complications at clinical evaluation 1–4 days after rectal resection. HRQOL was evaluated at 3, 6 and 12 months after resection using the European Organisation for Research and Treatment of Cancer (EORTC) questionnaires QLQ‐C30 and QLQ‐CR29 and Short Form 36 (SF‐36®).
There were 112 patients available for analysis. Response rates of the questionnaires were 82–95 per cent, except for EORTC QLQ‐C30 at 12 months, to which only 54–55 per cent of the patients responded owing to an error in questionnaire distribution. There were no clinically significant differences in any questionnaire scores between the groups at 3, 6 or 12 months.
Although the randomized study found that early closure of the temporary ileostomy was associated with significantly fewer complications, this clinical advantage had no effect on the patients' HRQOL. Registration number: NCT01287637 (
You may also be interested in
Preliminary results of a cohort study of induction chemotherapy‐based treatment for locally recurrent rectal cancer.
Authors: D. M. G. I. van Zoggel, S. J. Bosman, M. Kusters, G. A. P. Nieuwenhuijzen, J. S. Cnossen, G. J. Creemers et al.
Notes: Promising responses
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.
Authors: H. Grut, S. Solberg, T. Seierstad, M. E. Revheim, T. S. Egge, S. G. Larsen et al.
Notes: Immunosuppression may not accelerate growth
MRI‐based score to predict surgical difficulty in patients with rectal cancer. BJS 2018; 105: 140-146.
Authors: L. Escal, S. Nougaret, B. Guiu, M. M. Bertrand, H. de Forges, R. Tetreau et al.
Notes: Imaging criteria predict surgical difficulty
Meta‐analysis of outcomes following resection of the primary tumour in patients presenting with metastatic colorectal cancer.
Authors: U. Nitsche, C. Stöß, L. Stecher, D. Wilhelm, H. Friess, G. O. Ceyhan et al.
Notes: Selected patients only
Population‐based study of factors predicting treatment intention in patients with locally recurrent rectal cancer. BJS 2017; 104: 1866-1873.
Authors: K. Westberg, G. Palmer, F. Hjern, C. Nordenvall, H. Johansson, T. Holm et al.
Notes: Defines good selection criteria
Outcome after restorative proctocolectomy and ileal pouch–anal anastomosis in children and adults. BJS 2017; 104: 1640-1647.
Authors: K. Diederen, S. S. Sahami, M. M. Tabbers, M. A. Benninga, A. Kindermann, P. J. Tanis et al.
Notes: Comparable in children and adults
Weekend admission and mortality for gastrointestinal disorders across England and Wales. BJS 2017; 104: 1723-1734.
Authors: S. E. Roberts, T. H. Brown, K. Thorne, R. A. Lyons, A. Akbari, D. J. Napier et al.
Notes: Worst for gastrointestinal cancer and liver disease
Randomized clinical trial
Randomized clinical trial of laparoscopic ultrasonography before laparoscopic colorectal cancer resection. BJS 2017; 104: 1462-1469.
Authors: S. B. Ellebæk, C. W. Fristrup, C. Hovendal, N. Qvist, L. Bundgaard, S. Salomon et al.
Notes: No additional benefit
Authors: K. Sahnan, A. Askari, S. O. Adegbola, P. J. Tozer, R. K. S. Phillips, A. Hart et al.
Notes: Women more likely to develop fistula
Short‐ and medium‐term outcomes following primary ileocaecal resection for Crohn’s disease in two specialist centres. BJS 2017; 104: 1713-1722.
Authors: A. de Buck van Overstraeten, E. J. Eshuis, S. Vermeire, G. Van Assche, M. Ferrante, G. R. D'Haens et al.
Notes: Clear margins and smoking cessation are key
Randomized clinical trial
Randomized clinical trial of percutaneous tibial nerve stimulation versus sham electrical stimulation in patients with faecal incontinence. BJS 2017; 104: 1167-1176.
Authors: A. A. van der Wilt, G. Giuliani, C. Kubis, B. P. W. van Wunnik, I. Ferreira, S. O. Breukink et al.
Notes: Limited case for PTNS